🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › New Jersey › Edison

Etid klinik pou Limfom Difize Gwo Selil B nan Edison, NJ

9 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Ap rekriteFaz 3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06091865

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick · 3 mi lwen
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Ap rekriteFaz 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
  • Astera Cancer Care, East Brunswick · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT06500273

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Ap rekriteFaz 1
  • START New Jersey, East Brunswick · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07424833

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Laj 65 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT06765317

SynKIR-310 for Relapsed/Refractory B-NHL

Ap rekriteFaz 1
  • Rutgers Cancer Institute, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Ap rekriteFaz 1 bonè
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT04512716

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT06736613

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Edison

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.